Lifevantage Corporation (NASDAQ:LFVN – Get Free Report) Director Michael Beindorff sold 10,000 shares of the stock in a transaction that occurred on Thursday, November 12th. The shares were sold at an average price of $4.89, for a total value of $48,900.00. Following the transaction, the director directly owned 31,625 shares of the company’s stock, valued at $154,646.25. This trade represents a 24.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Lifevantage Stock Down 4.0%
NASDAQ:LFVN opened at $4.77 on Tuesday. The firm has a market capitalization of $60.48 million, a price-to-earnings ratio of 11.72 and a beta of 0.71. Lifevantage Corporation has a twelve month low of $3.90 and a twelve month high of $11.71. The stock’s 50 day moving average price is $5.90 and its two-hundred day moving average price is $5.85.
Lifevantage (NASDAQ:LFVN – Get Free Report) last posted its quarterly earnings results on Monday, November 9th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.01). The firm had revenue of $37.12 million for the quarter, compared to the consensus estimate of $40.49 million. Lifevantage had a return on equity of 16.35% and a net margin of 1.58%.
Lifevantage Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date of this dividend is Tuesday, December 1st. Lifevantage’s payout ratio is 95.24%.
Analyst Ratings Changes
A number of analysts have recently issued reports on the company. Zacks Research cut Lifevantage from a “hold” rating to a “strong sell” rating in a research report on Friday, October 16th. Freedom Broker decreased their target price on Lifevantage from $9.00 to $8.00 and set a “buy” rating on the stock in a report on Friday. Weiss Ratings cut Lifevantage from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday. UBS Group set a $8.00 price target on Lifevantage in a research note on Friday. Finally, Lake Street Capital raised their target price on shares of Lifevantage from $5.00 to $6.00 and gave the stock a “hold” rating in a report on Friday, August 28th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $6.75.
View Our Latest Analysis on LFVN
Institutional Investors Weigh In On Lifevantage
Several large investors have recently modified their holdings of the company. Hsbc Holdings PLC bought a new position in shares of Lifevantage in the 1st quarter worth about $51,000. Bank of New York Mellon Corp acquired a new stake in Lifevantage during the second quarter worth approximately $78,000. Bank of America Corp DE grew its stake in Lifevantage by 24.3% during the first quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock worth $101,000 after purchasing an additional 4,586 shares during the period. Finally, Engineers Gate Manager LP grew its stake in Lifevantage by 109.7% during the second quarter. Engineers Gate Manager LP now owns 27,009 shares of the company’s stock worth $169,000 after purchasing an additional 14,131 shares during the period. 35.32% of the stock is currently owned by institutional investors and hedge funds.
About Lifevantage
LifeVantage Corporation is a health and wellness company that develops and sells dietary supplements, skincare products and other wellness offerings. Its product range includes Protandim supplements and the TrueScience skincare line, with products marketed around the company’s focus on nutrigenomics—the study of how nutrition interacts with gene expression. Founded in 2003, LifeVantage primarily sells through independent consultants and online channels. The company serves customers in markets across North America, Europe and the Asia-Pacific region.
Further Reading
- Five stocks we like better than Lifevantage
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Lifevantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifevantage and related companies with MarketBeat.com's FREE daily email newsletter.
